Literature DB >> 22294211

Prevalence and spectrum diseases predisposing to sudden cardiac death: are they the same for both the athlete and the nonathlete?

Anjan S Batra1, Seshadri Balaji.   

Abstract

Sudden cardiac death (SCD) is a rare but devastating event among young people. The precise scale of the event remains undefined. This uncommon but catastrophic event usually is proved to be the consequence of varied unsuspected congenital or acquired cardiovascular diseases. Hypertrophic cardiomyopathy and coronary artery anomalies are the two most frequent causes of SCD. Most commonly, SCD resulting from these diseases occurs during or immediately after exercise. This report highlights the prevalence and spectrum of SCD-predisposing diseases and how they are affected by athletic participation. In addition, disease-specific guidelines for sports participation are addressed.

Entities:  

Mesh:

Year:  2012        PMID: 22294211     DOI: 10.1007/s00246-012-0159-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  43 in total

1.  Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers.

Authors:  Hein Heidbüchel; Nicole Panhuyzen-Goedkoop; Domenico Corrado; Ellen Hoffmann; Allessandro Biffi; Pietro Delise; Carina Blomstrom-Lundqvist; Luc Vanhees; Per Ivarhoff; Uwe Dorwarth; Antonio Pelliccia
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2006-08

2.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.

Authors:  Domenico Corrado; Cristina Basso; Andrea Pavei; Pierantonio Michieli; Maurizio Schiavon; Gaetano Thiene
Journal:  JAMA       Date:  2006-10-04       Impact factor: 56.272

3.  Catheter ablation in competitive athletes: indication.

Authors:  F Furlanello; A Bertoldi; G Inama; F Fernando
Journal:  J Interv Cardiol       Date:  1995-12       Impact factor: 2.279

Review 4.  Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities.

Authors:  B J Maron; J H Mitchell
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

5.  Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Raymond W Sy; Michael H Gollob; George J Klein; Raymond Yee; Allan C Skanes; Lorne J Gula; Peter Leong-Sit; Robert M Gow; Martin S Green; David H Birnie; Andrew D Krahn
Journal:  Heart Rhythm       Date:  2011-02-09       Impact factor: 6.343

6.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.

Authors:  A Pelliccia; B J Maron; F Culasso; A Spataro; G Caselli
Journal:  JAMA       Date:  1996-07-17       Impact factor: 56.272

Review 7.  State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young.

Authors:  Michael J Ackerman
Journal:  Pacing Clin Electrophysiol       Date:  2009-07       Impact factor: 1.976

8.  Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.

Authors:  Barry J Maron; Tammy S Haas; Joseph J Doerer; Paul D Thompson; James S Hodges
Journal:  Am J Cardiol       Date:  2009-05-18       Impact factor: 2.778

9.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

10.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.